BioCentury
ARTICLE | Financial News

Lilly Asia Ventures leads $15M EdiGene round

August 10, 2018 6:57 PM UTC

Gene editing company EdiGene Inc. (Beijing, China) raised about $15 million in a preseries B round led by Lilly Asia Ventures. New investor Huagai Capital participated alongside existing investors IDG Capital, WI Harper Group and other undisclosed investors...

BCIQ Company Profiles

EdiGene Inc.